Stay updated on Avapritinib in Advanced Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib in Advanced Mastocytosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA 403 Forbidden error page is displayed for the study page, replacing the usual study record content. The previously visible study documents and details appear removed or inaccessible due to the error.SummaryDifference19%

- Check19 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.6 to Revision: v3.7.0, indicating a new build of the page without changes to the study information.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a newer version of the page. The change represents an update to the page's revision history with a new version number.SummaryDifference0.0%

- Check40 days agoChange DetectedA new identifier '2017 ( U.S. NIH Grant/Contract )' was added to the PATHFINDER study's list of Other Study ID Numbers, indicating NIH-related funding/contract information associated with the trial.SummaryDifference0.0%

- Check54 days agoChange DetectedA new revision tag appears: Revision: v3.6.5, replacing Revision: v3.6.4. This signals a minor backend/template update rather than a change to the page's substantive content or functionality.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a minor internal revision label rather than any change to study content or results.SummaryDifference0.0%

Stay in the know with updates to Avapritinib in Advanced Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.